1362 related items for PubMed ID: 11129128
1. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
2. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
Lyseng-Williamson KA, Plosker GL.
Pharmacoeconomics; 2003 Nov; 21(13):951-89. PubMed ID: 12959627
[Abstract] [Full Text] [Related]
3. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
Markham A, Adkins JC.
Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397
[Abstract] [Full Text] [Related]
4. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Reynolds NA, Lyseng-Williamson KA, Wiseman LR.
Drugs; 2005 Dec; 65(12):1715-34. PubMed ID: 16060707
[Abstract] [Full Text] [Related]
5. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[Abstract] [Full Text] [Related]
6. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
7. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[Abstract] [Full Text] [Related]
8. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
9. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
Pharmacoeconomics; 2004 Dec; 22(12):815-25. PubMed ID: 15294013
[Abstract] [Full Text] [Related]
10. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[Abstract] [Full Text] [Related]
11. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B, Faulds D.
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[Abstract] [Full Text] [Related]
12. Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
Pieters WR, Wilson KK, Smith HC, Tamminga JJ, Sondhi S.
Treat Respir Med; 2005 May; 4(2):129-38. PubMed ID: 15813665
[Abstract] [Full Text] [Related]
13. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
Can Respir J; 1999 May; 6(1):45-51. PubMed ID: 10202220
[Abstract] [Full Text] [Related]
14. Salmeterol/fluticasone propionate combination.
Spencer CM, Jarvis B.
Drugs; 1999 Jun; 57(6):933-40; discussion 941-3. PubMed ID: 10400406
[Abstract] [Full Text] [Related]
15. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A, Jacques L, Frith L.
Clin Drug Investig; 2008 Jun; 28(3):169-81. PubMed ID: 18266402
[Abstract] [Full Text] [Related]
16. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
17. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[Abstract] [Full Text] [Related]
18. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
Lenney W, McKay AJ, Tudur Smith C, Williamson PR, James M, Price D, MASCOT Study Group.
Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
[Abstract] [Full Text] [Related]
19. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C, Wu EQ, Ray S, Colice GL.
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[Abstract] [Full Text] [Related]
20. Salmeterol/fluticasone propionate: a review of its use in asthma.
McKeage K, Keam SJ.
Drugs; 2009 Dec; 69(13):1799-828. PubMed ID: 19719334
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
